The global swab and viral transport medium market size was valued at USD 8.82 billion in 2023, driven by the increasing awareness among government and them realizing the potential of swab and viral transport medium across the globe. The market size is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032 to achieve a value of USD 14.66 billion by 2032.
Viral transport medium (VTM) is a solution used for maintaining virus specimens after collection, so that they can be transferred and examined in a lab later. Virus samples and RNA virus samples, in particular, are prone to deterioration unless kept in a liquid nitrogen or ultra-low temperature freezer. However, because of their large size, heavy weight, and in the case of freezers, considerable energy consumption, such cooling equipment is rarely available in the field. Consequently, the necessity for VTM, a chemical preservative, that may be applied at room temperature, exists. Saline solution, phosphate-buffered saline (PBS), and foetal bovine serum are examples of possible chemical components.
This rise in the prevalence of several infectious diseases around the world has caused an increase in demand for swabs and transport mediums, which in turn has led to the market's expansion. The market for swabs and viral transport medium is also expanding as these rising infectious diseases have the potential to cause a variety of diseases in humans which further requires the swab and viral transport medium for diagnosis purposes.
Due to the rising demand for specimen collection kits and diagnosis, the prevalence of different infectious diseases is anticipated to propel the global swab and viral transport medium market growth. As the pandemic expanded widely over the world, the need for laboratory testing of the samples and the detection of the infectious virus increased. Additionally, the government approvals for the usage of transport media are also a contributing factor for the growth of the market.
Market Breakup by Type
Market Breakup by Applications
Market Breakup by End User
Market Breakup by Region
Due to the integration of advanced technologies, such as artificial intelligence, automation and robotics in testing processes are in increased demand. The robotic-friendly swabs and transport mediums that can be seamlessly incorporated into high-throughput testing systems are driving the global swab and viral transport medium market growth. The increase in popularity of swabs that are designed for collecting multiple types of samples is also driving the market growth. These swabs are flexible and convenient in different testing scenarios.
The market is experiencing a significant shift towards eco-friendly materials to manufacture swabs in order to address the growing sustainability concerns across the globe, which is further propelling the growth of the global swab and viral transport medium market. Additionally, the development of specifically designed swabs and viral transport mediums for specific genetic testing needs is also contributing to the market growth with increasing advancements in genetics and personalized medicine across the globe.
North America is leading the global market due to the presence of robust healthcare facilities and increasing infection control initiatives by the government. The increasing demand for quick diagnosis is a major factor driving the market growth. The increasing funding activities from the public and private organizations are among the major factors contributing to the growth of the market.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type
|Breakup by Applications
|Breakup by End User
|Breakup by Region
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Swab and Viral Transport Medium Market Overview
3.1 Global Swab and Viral Transport Medium Market Historical Value (2017-2023)
3.2 Global Swab and Viral Transport Medium Market Forecast Value (2024-2032)
4 Global Swab and Viral Transport Medium Market Landscape
4.1 Global Swab and Viral Transport Medium: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Swab and Viral Transport Medium: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Swab and Viral Transport Medium Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Swab and Viral Transport Medium Market Segmentation
6.1 Global Swab and Viral Transport Medium Market by Type
6.1.1 Market Overview
6.1.2 Swab Type (Nasopharyngeal Swabs, Throat Swabs)
6.1.3 Transport Medium
6.2 Global Swab and Viral Transport Medium Market by Applications
6.2.1 Market Overview
6.2.4 Herpes Simplex Virus
6.3 Global Swab and Viral Transport Medium Market by End User
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Diagnostic Laboratories
6.4 Global Swab and Viral Transport Medium Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Swab and Viral Transport Medium Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Swab and Viral Transport Medium Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Swab and Viral Transport Medium Market
9.1 Market Share by Country
10 Latin America Swab and Viral Transport Medium Market
10.1 Market Share by Country
11 Middle East and Africa Swab and Viral Transport Medium Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 ThermoFisher Scientific
15.1.1 Financial Analysis
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.3 Dickinson and Company
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.4 Titan Biotech Limited
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.5 Copan Diagnostic inc
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.6 Medical Wire and Equipment
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.7 Puritan Medical Products
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.8 Yocon Biology
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.9 Trinity Biotech
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 8.82 billion in 2023, driven by the increasing infectious diseases.
The market is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032, likely to reach a market value of USD 14.66 billion by 2032.
The rising geriatric population and increasing investments from governments and key players in research and development activities are among the major factors driving the market growth.
The increasing demand for quick diagnosis and increasing research and development for the observation of infectious diseases across the globe are among the major trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The swab type (nasopharyngeal swabs, throat swabs) and transport medium are available in the market.
The end users in the market include hospitals and clinics, diagnostic laboratories, among others.
They find wide applications in COVID-19, influenza, and herpes simplex virus, among others.
Key players involved in the market are ThermoFisher Scientific, Becton, Dickinson and Company, Titan Biotech Limited, Copan Diagnostic inc, Medical Wire and Equipment., Puritan Medical Products, Yocon Biology, Trinity Biotech, and Vircell.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.